In thyroid cancer, Raf1, a direct target of miR-195, was significantly upregulated in thyroid carcinomas compared to benign tumors and miR-195 overexpression dramatically decreased the protein level of Raf1 and inhibited cell proliferation in thyroid cancer [28]. This evidence concerns the gene RAF1 and benign neoplasm.